Summits On Demand

CURE®'s Educated Patient® Summits are half-day events seeking to update, educate and inform the thinking of patients with cancer, as well as their caregivers and advocates. The programs are designed to represent every demographic of patient and all stages of cancer. Depending upon cancer type, agenda topics presented by specialized cancer doctors and patient group leaders may include diagnosis, treatment options, genomics, long term effects, clinical trials and much more.

Watch and share the on-demand video anytime to hear the valuable content provided by our presenting faculty and advocacy groups, as well as hear responses to viewer submitted questions. Experience the full virtual environment and visit the exhibit hall by registering and logging in to the portal.

View Upcoming Patient Summits

Educated Patient® Multiple Myeloma Summit Role of the Healthy Immune System Presentation: November 13, 2022

December 1st 2022, 2:00pm

Video

Watch Dr. David Coffey, from Sylvester Comprehensive Cancer Center at the University of Miami, discuss the role of a healthy immune system during the CURE® Educated Patient® Multiple Myeloma Summit.

Educated Patient® Multiple Myeloma Summit Novel Treatments for the Newly Diagnosed Presentation: November 13, 2022

November 30th 2022, 2:00pm

Video

Watch Dr. C. Ola Landgren, from Sylvester Comprehensive Cancer Center at the University of Miami, discuss novel treatments for newly diagnosed patients during the CURE® Educated Patient® Multiple Myeloma Summit.

Educated Patient® Metastatic Breast Cancer Summit Addressing Unmet Needs Panel: November 12, 2022

November 29th 2022, 2:00pm

Video

Watch Dr. Leif Ellisen, Dr. Dejan Juric, Dr. Beverly Moy and Natasha Mmeje answer questions about unmet needs during the CURE Educated Patient Metastatic Breast Cancer Summit.

Educated Patient® Metastatic Breast Cancer Summit Addressing Breast Cancer Disparity Presentation: November 12, 2022

November 28th 2022, 2:00pm

Video

Watch Dr. Beverly Moy, from Massachusetts General Hospital, discuss addressing breast cancer disparity during the CURE Educated Patient Metastatic Breast Cancer Summit.

Educated Patient® Metastatic Breast Cancer Summit Addressing Therapeutic Resistance Presentation: November 12, 2022

November 27th 2022, 3:00pm

Video

Watch Dr. Dejan Juric, from Massachusetts General Hospital, discuss therapeutic resistance during the CURE Educated Patient Metastatic Breast Cancer Summit.

Educated Patient® Metastatic Breast Cancer Summit HER2 and Triple-Negative Disease Panel: November 12, 2022

November 26th 2022, 3:00pm

Video

Watch Dr. Aditya Bardia, Dr. Arielle J. Medford and Dr. Neelima Vidula answer questions about HER2 and triple-negative disease during the CURE Educated Patient Metastatic Breast Cancer Summit.

Educated Patient® Metastatic Breast Cancer Summit Management of Triple Negative Disease Presentation: November 12, 2022

November 25th 2022, 2:00pm

Video

Watch Dr. Neelima Vidula, from Massachusetts General Hospital, discuss the management of triple-negative disease during the CURE Educated Patient Metastatic Breast Cancer Summit.

Educated Patient® Metastatic Breast Cancer Summit: November 12, 2022

November 24th 2022, 2:00pm

Video

Watch Dr. Arielle J. Medford, from Dana-Farber Cancer Institute, discuss the management of HER2-positive disease during the CURE® Educated Patient® Metastatic Breast Cancer Summit.

Educated Patient® Metastatic Breast Cancer Summit HR-Positive Disease Panel: November 12, 2022

November 23rd 2022, 2:00pm

Video

Watch Dr. Aditya Bardia, Dr. Seth A. Wander and Dr. Laura M. Spring answer questions about HR-positive disease during the CURE Educated Patient Metastatic Breast Cancer Summit.

Educated Patient® Metastatic Breast Cancer Summit Overview of Management of Hormone Receptor-positive Breast Cancer: Third Line and Beyond Presentation: November 12, 2022

November 22nd 2022, 2:00pm

Video

Watch Dr. Laura M. Spring, from Massachusetts General Hospital in Boston, discuss treatment in third line and beyond for hormone receptor-positive breast cancer, during the CURE® Educated Patient® Metastatic Breast Cancer Summit.